CLRN (CLRN) Stock Price & Analysis
CLRN (CLRN) rose 0.00% to USD 0 as of June 10, 2026 at 15:40 UTC, according to Nexqual real-time market data.
CLRN last closed at USD 0; the session ranged USD 0–0 on volume of 25 shares. Market capitalization is $492,017, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 15:40 UTC.
Key Statistics (as of June 10, 2026 at 15:40 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 25 shares |
| Market Cap | $492,017 |
| Exchange | PNK |
Technical Analysis (CLRN)
Nexqual's technical model rates CLRN "SELL" based on 0 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 15:40 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (CLRN)
Wall Street analysts rate CLRN "None", per Nexqual as of June 10, 2026 at 15:40 UTC.
| Consensus Rating | None |
|---|
Earnings (CLRN)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2001-06-30 | USD -0.24 vs est -0.19 ▼ miss |
| 2001-03-31 | USD -0.05 vs est -0.04 ▼ miss |
| 2000-12-31 | USD -0.05 vs est -0.06 ▲ beat |
| 2000-09-30 | USD 0.04 vs est -0.03 ▲ beat |
Source: Nexqual, June 10, 2026 at 15:40 UTC.
Financials & Fundamentals (CLRN)
| Total Revenue | $94.59M |
|---|---|
| Revenue Growth (YoY) | -31.20% |
| Gross Margin | -26.48% |
| Operating Margin | -395.00% |
| Profit Margin | +0.00% |
| ROE | -166.03% |
| Debt / Equity | 24.95 |
| Current Ratio | 1.61 |
| Total Cash | $86.28M |
| Total Debt | $9.96M |
| Free Cash Flow | $-77.70M |
Source: Nexqual, June 10, 2026 at 15:40 UTC.
Financial Health Score (CLRN)
Nexqual rates CLRN's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 15:40 UTC.
| Growth | Critical — Revenue -31% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $86M cash vs $10M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$78M, burning cash |
| Efficiency | Critical — ROE -166%, ROA -43.2% |
Ownership (CLRN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 0 |
Source: Nexqual, June 10, 2026 at 15:40 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ACRU | AMERICREW INC | USD 0.01 | ▲ 0% |
| MCOM | Micromobility.com Inc. | USD 0.01 | ▲ 0% |
| ASPT | ALADDIN SEPARATION TECHNOLOGIES | USD 0 | ▲ 0% |
| INTI | Inhibitor Therapeutics Inc. | USD 0.09 | ▲ 0% |
| ATGN | Altigen Communications, Inc. | USD 0.5 | ▲ 6.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 15:40 UTC. This page is informational and not investment advice.